NY-HOTWIRE
2.2.2021 16:05:12 CET | Business Wire | Press release
Hotwire, the global technology communications consultancy, today announced it will commit up to $1 million in services to support tech and tech-enabled organizations led by or supporting minority communities. The Program is part of Hotwire’s Diversity, Equity, and Inclusion (DEI) strategy to amplify people and organizations creating meaningful and sustainable change in the world through technology innovation.
“We started the Hotwire Ignite Possibility Program to direct more of our resources to organizations that align with our diversity, equity, and inclusion goals,” said Barbara Bates, CEO. “We have been providing pro bono services to impactful organizations for years, but now, with the Hotwire Ignite Possibility Program, we can do more to advance social justice through our services.”
Any tech or tech-enabled organization—for-profit, non-profit, education, or government—that is either minority-led or providing a product or service benefitting minority communities in a country with a Hotwire office may qualify. Hotwire will work with local community tech leaders addressing inequalities in business and tech to reach organizations who can benefit from brand, marketing or PR pro bono services.
“Having recently had the honor of being named Global Technology Agency of the Year by PRovoke Media, we have a responsibility to lead by example and address the inequality of resources for tech organizations,” noted Bates. “The Hotwire Ignite Possibility Program is one way we can do that,” she added.
Hotwire’s DEI strategy launched in early 2020 and includes specific commitments and a phased rollout schedule. Starting with internal operations and employee engagement initiatives aimed at building a diverse employee population and creating an inclusive environment where differences are celebrated, the firm is now extending the focus externally with the Hotwire Ignite Possibility Program. Hotwire has also signed the Diversity Action Alliance commitment, joining other PR and communications leaders to accelerate progress in the achievement of meaningful and tangible results in diversity, equity and inclusion across our profession.
By earmarking up to $1 million in services to organizations that meet the selection criteria, Hotwire is increasing the amount of support they provide to tech organizations in need of brand, marketing, and public relations expertise that otherwise may not have had access to these resources. The end goal of the Program is to help more tech and tech-enabled organizations that are advancing diversity, equity, and inclusion through technology innovation scale and succeed in today’s competitive tech sector.
Applications are now open for organizations in the US , UK and Germany until March 15th , 2021. An announcement of selected organizations in those countries will be made in April 2021. Applications for Australia open later in 2021 and Hotwire may reopen applications in other regions throughout the year. Follow us on Twitter and LinkedIn to get updates. Have questions? Email HIPP@hotwireglobal.com
About Hotwire
Hotwire is the global technology communications consultancy. Founded in 2000, we operate a worldwide network of wholly owned offices and partners serving a range of clients from scale ups to established multi-nationals. We unleash the possibilities of innovative technology through integrated communications that ignite curiosity, spark action and fuel success. We do this using our proprietary methodology which is underpinned by robust insight and strategy, purposeful creative, integrated planning and a core emphasis on measurement and evaluation.
About Enero
The Enero Group limited, a boutique network of marketing and communication businesses, is listed on the Australian Securities Exchange (asx:EGG). The group includes advertising agency BMF, PR agencies CPR, Frank and Hotwire, digital agency Orchard, research consultancies The Leading Edge and The Digital Edge, and programmatic marketing specialist OB media. For more information, please visit www.enero.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210202005795/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
